Table 1

Demographics and comorbidities of congenital scoliosis patients who underwent posterior fusion (N = 816).

Variables n (%)
Age, y mean ± SD11.32 ± 4.02
Age, y
 0–483 (10.2)
 5–9131 (16.1)
 10–14423 (51.8)
 15–19179 (21.9)
Sex
 Women468 (57.4)
 Men348 (42.7)
Body mass index group
 Underweight (<18.5 kg/m2)363 (44.5)
 Nonobese (18.5–29.9 kg/m2)392 (48.0)
 Obese I (30.0–34.9 kg/m2)42 (5.2)
 Obese II (35.0–39.9 kg/m2)14 (1.7)
 Obese III (≥40 kg/m2)5 (0.6)
Nutritional support49 (6)
Esophageal/gastric/intestinal disease98 (12.0)
Ionotropic support during surgery8 (1.0)
Seizure disorder35 (4.3)
Tracheostomy13 (1.6)
Chronic steroid use4 (0.5)
Developmental delay189 (23.2)
Previous cardiac surgery98 (12.0)
Chronic lung disease58 (7.1)
Structural central nervous system abnormality183 (22.4)
Asthma89 (10.9)
Oxygen support16 (2.0)
Hematological disease20 (2.5)
Structural pulmonary/airway abnormality91 (11.2)
Blood transfusions within 48 h prior to surgery4 (0.5)
American Society of Anesthesiologists Score
 1–2458 (56.1)
 >2358 (43.9)
Fusion to pelvis61 (7.5)
Osteotomy254 (31.1)
Levels fused
 <7302 (37.0)
 7–12304 (37.3)
 >12210 (25.7)
Length of stay, d4.64 ± 3.71
Readmission43 (5.3)
  • Note: Data presented as n (%) unless otherwise indicated.